NEW YORK--Manhattan Scientifics, Inc. (Pink Sheets: MHTX) announced today that the company is fully reporting and that its stock will be quoted on OTC Bulletin Board.
CEO Manny Tsoupanarias expressed thanks to Manhattan Scientifics' 8,500 shareholders for their patience and continued belief in the Company's work.
Manhattan Scientifics, Inc. (www.mhtx.com) is located in New Mexico, New York and Montreal. It is focused on technology transfer and commercialization of disruptive technologies in the nano medicine space. The company is presently developing commercial medical prosthetics applications for its ultra-fine grain metals and plans to commercialize the cancer research work and nano medical applications developed by Senior Scientific LLC, a unit of the Company.
This press release contains forward-looking statements. Such forward-looking statements are subject to a number of risks, assumptions and uncertainties that could cause the Company's actual results to differ materially from those projected in such forward-looking statements. Forward-looking statements speak only as of the date made and are not guarantees of future performance. We undertake no obligation to publicly update or revise any forward-looking statements.